Have you been diagnosed with Metastatic Castration-Resistant Prostate Cancer (mCRPC)?

Find out if you qualify to participate in a clinical trial of an investigational therapy designed to activate the immune system and enable it to fight cancer throughout the body.

Have you been diagnosed with Metastatic Castration-Resistant Prostate Cancer (mCRPC)?

Find out if you qualify to participate in a clinical trial of an investigational therapy designed to activate the immune system and enable it to fight cancer throughout the body.

LEGION-100 Clinical Trial

ClinicalTrials.gov ID Number: NCT06533644

This clinical trial is studying an investigational therapy called SYNC-T Therapy SV-102. It is a combination therapy that freezes a portion of a tumor and then infuses a drug directly into the tumor. The therapy is designed to activate the immune system and enable it to fight cancer throughout the body.

Have you been diagnosed with Metastatic Castration-Resistant Prostate Cancer (mCRPC)?

Find out if you qualify to participate in a clinical trial of an investigational therapy designed to activate the immune system and enable it to fight cancer throughout the body.

Have you been diagnosed with Metastatic Castration-Resistant Prostate Cancer (mCRPC)?

Find out if you qualify to participate in a clinical trial of an investigational therapy designed to activate the immune system and enable it to fight cancer throughout the body.

LEGION-100 Clinical Trial

ClinicalTrials.gov ID Number: NCT06533644

About Prostate Cancer

About Clinical Trials

For Healthcare Professionals

Find out if you qualify to participate in this clinical trial of an investigational therapy designed to activate the immune system and enable it to fight cancer throughout the body.